Chancellor Michael B has filed 3 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 80000 shares of LIPELLA PHARMACEUTICALS INC. ($LIPO) on March 15, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 15, 2024 | LIPELLA PHARMACEUTICALS INC. | $LIPO | Chancellor Michael B | Chief Medical Officer | A | Stock Options | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| March 13, 2024 | LIPELLA PHARMACEUTICALS INC. | $LIPO | Chancellor Michael B | Chief Medical Officer | A | Common Stock | 144906 | $0.69 | 877,637.0000 | 0 | 19.78% | 0.00% |
| June 16, 2023 | LIPELLA PHARMACEUTICALS INC. | $LIPO | Chancellor Michael B | Chief Medical Officer | A | Stock Options | 79500 | $0.00 | 79,500.0000 | 0 | 9999.99% | 0.00% |